Segundo o gerente, uma avaliao de resultado regulatrio est em finalizao e deve ser divulgada em breve
Last reviewed: May 17, 2026 Last updated: May 17, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Quality of evidence: I-A, Strength of recommendation: 1 Panel level of agreement: In total agreement 96%, in partial agreement 4% Lactulose is the most widely used nonabsorbable disaccharide for the treatment of HE
If you want a broader breakdown of placement, GLP-1 injection sites for all medications offers a helpful reference
Rico-Fontalvo, J., Daza-Arnedo, R., Raad-Sarabia, M., Pjaro-Galvis, N., Correa-Guerrero, J., Villacob-Oviedo, A., & Franco, E